Lynette Stanton
Lynette Stanton was the in-house counsel for Douglas Pharmaceuticals during the discussions surrounding the Trans-Pacific Partnership (TPP), which posed potential challenges for the company due to its focus on generic drug production and the implications of extended patent protections favored by larger pharmaceutical firms.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Lynette Stanton was the in-house counsel for Douglas Pharmaceuticals who discussed the implications of the TPP.
5